Vividion is a next-generation biotechnology company focused on expanding the therapeutic potential of small molecules. Making accessible the broad set of proteins expressed in human cells, the company's cutting-edge platform was spun out of the labs of Vividion's scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA. Vividion is committed to advancing and applying its pioneering proteome-wide drug discovery to create life-changing therapeutics.